Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.51 |
| ▸ | CASP3 | P42574 | 2/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.47 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22444637 | 1.00 | MDM4 (0.52) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL29855217 | 1.00 | MDM4 (0.52) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL17054258 | 1.00 | MDM4 (0.52) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL17054257 | 0.92 | FABP5 (0.48) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL22444747 | 0.89 | MDM2 (0.54) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL29221361 | 0.89 | MDM2 (0.50) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL29221362 | 0.89 | MDM2 (0.50) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL38666359 | 0.89 | MDM2 (0.53) | MDM4TP53MDM2CASP3ALDH1A1 | |
| SCHEMBL30819623 | 0.88 | MDM4 (0.48) | MDM4TP53MDM2CASP3FABP5 | |
| SCHEMBL27393663 | 0.88 | MDM4 (0.48) | MDM4TP53MDM2CASP3FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117279655-A | Pharmaceutical use of cyclic peptide compounds | 中外制药株式会社 | 2023-12-22 | — | — | CN | disclosed |
| EP-4135738-A2 | METHOD OF TREATING CORONAVIRUS INFECTIONS | Cohbar Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| EP-4058465-A1 | CXCR4 ANTAGONIST PEPTIDES | Cohbar Inc. (US) | 2022-09-21 | — | — | EP | disclosed |
| CN-114269367-A | Therapeutic peptides | 科巴公司 | 2022-04-01 | — | — | CN | disclosed |